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Is hospital mortality higher at weekends? If so, why?
In the past few years, politicians, the media, clinicians, 
and managers have become increasingly interested 
in the risks involved in being admitted to hospital at 
weekends. Although higher neonatal mortality has 
been reported for babies born at weekends than for 
those born during the week in the USA,1 the UK,2 and 
Australia3 since the 1970s, the ﬁ rst investigation of a 
weekend eﬀ ect in other areas of hospital care was not 
reported until 2001. Bell and Redelmeier4 reported 
higher mortality rates for weekend admissions than for 
weekday admissions for 23 of the 100 leading causes of 
death in Canadian hospitals. Since then, studies from 
around the world have likewise shown diﬀ erences in 
mortality between patients admitted at weekends and 
those admitted during the week. In England, in 2010, 
Aylin and colleagues5 showed that the odds of death for 
emergency admissions were 10% higher at weekends 
than during the week and, in 2012, Freemantle and 
protection,8,9 given the potential of wild polioviruses 
to circulate in populations immunised with IPV alone 
(as reported recently in Israel),10 it is unlikely that this 
protection would be suﬃ  cient to curb the spread of 
a serotype 2 circulating vaccine-derived poliovirus, 
especially in settings where poor sanitation and 
hygiene facilitate faecal–oral transmission.
Several gaps in our understanding of poliovirus 
immunity remain. Of the infants in this study who 
had not seroconverted to serotype 2 before receiving 
mOPV2, seroconversion 1 week after challenge was 
recorded in 127 (71%) of 179 who had received bOPV 
alone and 20 (53%) of 38 who had received bOPV 
alongside one dose of IPV. These infants were believed 
to have been “primed”—an interpretation shared 
by other recent trials that have reported a similar 
phenomenon.6,7 However, we remain uncertain as to the 
cause of this priming through homotypic or heterotypic 
mechanisms, and whether or not primed individuals are 
protected from paralytic disease. Moreover, given that 
serum neutralising antibodies might begin to appear 
within 7 days following primary exposure to OPV,11 this 
deﬁ nition of priming is up for debate.
We are entering a phase of major transition in polio 
immunisation. Even with the encouraging response 
to serotype 2 reported in this study after one dose 
of IPV, poor routine immunisation coverage in high-
risk areas and the risk of circulating vaccine-derived 
poliovirus emergence after tOPV withdrawal mean 
that serotype 2 poliovirus remains a threat to the polio 
endgame strategy. High-quality surveillance for cases 
of poliomyelitis alongside enhanced monitoring of 
waste water and sewage will be key to identifying the 
persistence of serotype 2 vaccine viruses after tOPV 
has been withdrawn. We must also be ready to respond 
rapidly with mOPV2 should an outbreak occur.
*Edward P K Parker, Nicholas C Grassly
Department of Infectious Disease Epidemiology, St Mary’s 
Campus, Imperial College London, London, UK
e.parker12@imperial.ac.uk
NCG is a member of the WHO Strategic Advisory Group of Experts polio working 
group. We declare no competing interests.
1 Platt LR, Estivariz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: 
a review of the epidemiology and estimation of the global burden. 
J Infect Dis 2014; 210 (suppl 1): S380–89.
2 Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. 
J Infect Dis 2014; 210 (suppl 1): S283–93.
3 WHO. Countries using and planning to introduce IPV and the global status 
of bOPV registration. 2016. http://www.who.int/entity/immunization/
diseases/poliomyelitis/endgame_objective2/IPV_2016_March.pptx?ua=1 
(accessed March 10, 2016).
4 Asturias EJ, Bandyopadhyay AS, Self S, et al, and the Latin American 
IPV001BMG Study Group. Humoral and intestinal immunity induced by 
new schedules of bivalent oral poliovirus vaccine and one or two doses of 
inactivated poliovirus vaccine in Latin American infants: an open-label 
randomised controlled trial. Lancet 2016; published online May 19. 
http://dx.doi.org/10.1016/S0140-6736(16)00703-0.
5 Estivariz CF, Anand A, Gary HE Jr, et al. Immunogenicity of three doses of 
bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 
2 week interval between doses in Bangladesh: an open-label, 
non-inferiority, randomised, controlled trial. Lancet Infect Dis 2015; 
15: 898–904.
6 O’Ryan M, Bandyopadhyay AS, Villena R, et al. Inactivated poliovirus 
vaccine given alone or in a sequential schedule with bivalent oral poliovirus 
vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, 
non-inferiority study. Lancet Infect Dis 2015; 15: 1273–82.
7 Sutter RW, Bahl S, Deshpande JM, et al. Immunogenicity of a new routine 
vaccination schedule for global poliomyelitis prevention: an open-label, 
randomised controlled trial. Lancet 2015; 386: 2413–21.
8 Ghendon YZ, Sanakoyeva II. Comparison of the resistance of the intestinal 
tract to poliomyelitis virus (Sabin’s strains) in persons after naturally and 
experimentally acquired immunity. Acta Virol 1961; 5: 265–73.
9 Parker EP, Molodecky NA, Pons-Salort M, O’Reilly KM, Grassly NC. Impact of 
inactivated poliovirus vaccine on mucosal immunity: implications for the 
polio eradication endgame. Expert Rev Vaccines 2015; 14: 1113–23.
10 Anis E, Kopel E, Singer SR, et al. Insidious reintroduction of wild poliovirus 
into Israel, 2013. Euro Surveill 2013; 18: 20586.
11 Ogra PL, Karzon DT. Distribution of poliovirus antibody in serum, 
nasopharynx and alimentary tract following segmental immunization of 
lower alimentary tract with poliovaccine. J Immunol 1969; 102: 1423–30.
Published Online
May 10, 2016
http://dx.doi.org/10.1016/
S0140-6736(16)30505-0
See Articles pages 170 and 178
Comment
www.thelancet.com   Vol 388   July 9, 2016 109
colleagues6 reported that mortality for all admissions 
(emergency and elective) was 11% higher on Saturdays 
and 16% higher on Sundays than on other days during 
the week.
Widespread interest in England about the possible 
dangers of being admitted to hospital at weekends has 
prompted several studies into why this might be, three 
of which have been published this week. In The Lancet, 
Cassie Aldridge and colleagues7 provide initial results 
from an ambitious cross-sectional study evaluating 
the eﬀ ect of a natural experiment oﬀ ered by the roll-
out of 7 day services in acute hospitals in England. 
With a focus on the eﬀ ect of medical specialist 
(consultant) staﬃ  ng levels, the investigators surveyed 
more than 15 000 specialists in 115 acute hospital 
trusts to obtain data for the time they each spent 
caring for emergency admissions on a Wednesday and 
on a Sunday. The estimated weekend eﬀ ect showed 
a 10% increase in mortality for weekend admissions 
(odds ratio 1·10 [95% CI 1·08–1·11]). Patients received 
only half as much specialist attention at weekends 
as on weekdays (median 21·90 [IQR 15·07–29·00] 
total specialist hours per ten emergency admissions 
on Sunday vs 42·73 h [33·37–55·36]). However, 
there was no signiﬁ cant association between 
intensity of specialist staﬃ  ng and mortality. In view 
of the response rate to the staﬀ  survey (45%), the 
limitations of basing adjusted mortality on hospital 
administrative data (which do not provide any 
biochemical or physiological indication of how sick 
patients are on admission), and the fact that the study 
did not consider availability of other staﬀ  (eg, junior 
doctors, nurses), the implications of these results 
should be interpreted with caution. Although Aldridge 
and colleagues’ ﬁ ndings challenge one of the most 
widely held views of the cause of higher weekend 
mortality, establishing whether increasing specialist 
staﬃ  ng levels is a beneﬁ cial approach must await their 
secular analyses over the next few years.
Meanwhile, also in The Lancet, Benjamin Bray and 
colleagues’8 interest is in the level of compliance with 
evidence-based clinical guidelines. With a focus on 
stroke care, the investigators overcome some of the 
limitations of administrative data by using a specialist 
clinical database that allows them to adjust mortality 
for diﬀ erences in the severity of admissions (using the 
US National Institutes of Health Stroke Score or level of 
consciousness) on weekdays and at weekends. Whereas 
a study of stroke admissions based on administrative 
data in 2009–10 reported a 26% higher mortality for 
weekend admissions than for weekday admissions,9 
Bray and colleagues’ study ﬁ nds no diﬀ erence in 30 day 
mortality in 2013–14; this diﬀ erence might reﬂ ect an 
improvement in weekend care or could be due to 
insuﬃ  cient casemix adjustment in the earlier study. 
Instead, the investigators suggest we should be more 
concerned about patients admitted at night, in whom 
mortality was 10% higher than in those admitted during 
the day (adjusted odds ratio 0·90 [95% CI 0·82–0·99]). 
As for adherence to clinical guidelines, such as 
door-to-needle time and a timely brain scan, patients 
admitted at night were less likely to receive eight of 
12 recommended interventions, which, they suggest, 
might contribute to heightened mortality. However, 
before drawing conclusions about the association 
between adherence to guidelines and outcomes, Bray 
and colleagues note that although patients admitted 
at the weekend were also less likely than weekend 
admissions to receive good quality care, this was not 
associated with higher mortality.
In a third innovative approach to investigating the 
cause of increased weekend mortality, Meacock and 
colleagues10 looked beyond the hospital to see the eﬀ ect 
of primary care. To do this, the investigators compared 
the two routes of emergency admissions: direct referrals 
(mostly from general practitioners) and patients 
admitted from accident and emergency departments. 
Whereas the daily number of admissions via accident 
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and emergency departments at weekends was similar to 
that on weekdays, the number of direct admissions was 
61% lower. While mortality for admissions via accident 
and emergency was only 5% higher at weekends, for 
direct admissions it was 21% higher. Given that, apart 
from initial treatment in accident and emergency, both 
sets of patients receive the same inpatient care, this 
ﬁ nding provides circumstantial evidence that mortality 
diﬀ erences are more likely to be attributable to how sick 
patients are on admission, rather than the quality of 
hospital care.
In view of these new, albeit inconsistent, insights 
into the possible dangers of weekend admissions, what 
conclusions can be drawn and what further  research is 
needed? First, caution should be taken in estimating the 
eﬀ ect on mortality. Previous studies based on routine 
administrative data did their best to use inventive 
and sophisticated methods to take casemix diﬀ erence 
between weekends and weekdays into account, but 
had little information about how sick patients were on 
admission. Studies using specialist clinical databases for 
speciﬁ c diseases or clinical departments, which include 
clinical and physiological data, have found little or no 
signiﬁ cant diﬀ erence by day of admission.8,11 Although 
more such studies are needed to identify which patients 
might be at risk of weekend admission, what is really 
needed is a study in which accurate measures of severity 
are available on all admissions, so that meaningful 
comparisons of weekends and weekdays for the whole 
hospital can be made. The increasingly wide use of 
electronic national early warning scores provides a 
means of doing that.12
Second, even if higher mortality at weekends is 
accounted for by patients being sicker than during 
the week, there is a widely held view plus anecdotal 
evidence that the quality of care is poorer at weekends. 
The reason this might not be manifest when 
investigators consider mortality is because death is not 
a particularly sensitive measure of quality given that 
only about 4% are thought to be avoidable.13 Attention 
should therefore be turned to other measures, such 
as health outcomes (morbidity, quality of life), safety 
(falls, hospital-acquired infections), aspects of patients’ 
experience (delays in diagnosis, not receiving suﬃ  cient 
information), operational eﬃ  ciency (extended lengths 
of stay, delayed discharges), and educational quality 
(training of junior doctors at weekends).
Third, perhaps the wrong determinants of poor 
outcome are being investigated. Maybe nurse staﬃ  ng 
levels or the availability of diagnostic staﬀ  should be 
assessed rather than medical staﬃ  ng.14 Or perhaps 
combinations of diﬀ erent professions. But even that 
approach might not be suﬃ  cient because research 
on inputs, such as staﬃ  ng levels, risks missing the 
processes of care, known to be the key determinants 
of poor quality care.15 For example, avoidable deaths 
in hospital happen when a patient’s deterioration 
remains undetected, when staﬀ  fail to communicate 
well with one another, and when the underlying 
culture of the organisation does not encourage 
and reward attitudes and behaviours that enhance 
quality.16 The importance of such organisational 
aspects was recognised in 2013 by National Health 
Service (NHS) England when they recommended ten 
national clinical standards for emergency admissions, 
including factors such as access to diagnostics and 
timely consultant review.17
Despite many claims about the quality of care at 
weekends and strong beliefs about the reasons for 
this, we need to remain open to the true extent 
and nature of any such deﬁ cit and to the possible 
causes. Jumping to policy conclusions without a clear 
diagnosis of the problem should be avoided because 
the wrong decision might be detrimental to patient 
conﬁ dence, staﬀ  morale, and outcomes. As Bray and 
colleagues warn, “Because solutions are likely to come 
at substantial ﬁ nancial and opportunity cost, policy 
makers, health-care managers, and funders need to 
ensure that the reasons for temporal variation in quality 
are properly understood and that resources are targeted 
appropriately.”8
Nick Black
Department of Health Services Research and Policy, London 
School of Hygiene & Tropical Medicine, London WC1H 9SH, UK
nick.black@lshtm.ac.uk
I chair NHS England’s National Advisory Group for Clinical Audit and Enquiries.
Copyright © Black. Open Access article distributed under the terms of CC BY.
1 Mangold WD. Neonatal mortality by the day of the week in the 1974–75 
Arkansas live birth cohort. Am J Public Health 1981; 71: 601–05.
2 McFarlane A. Variations in number of births and perinatal mortality by the 
day of week in England and Wales. BMJ 1978; 2: 1670–73
3 Mathers CD. Births and perimatal deaths in Australia: variations by day of 
week. J Epidemiol Community Health 1983; 37: 57–62.
4 Bell CM, Redelmeier DA. Mortality among patients admitted to hospitals 
on weekends as compared with weekdays. N Engl J Med 2001; 
345: 663–68.
Comment
www.thelancet.com   Vol 388   July 9, 2016 111
In the past decade, treatment of multiple myeloma 
has progressed greatly as a result of several new active 
drugs, especially lenalidomide and bortezomib.1,2 In 
late 2015, three additional new drugs—elotuzumab, 
daratumumab, and ixazomib—were approved by the 
US Food and Drug Administration within the space 
of 2 weeks.3–5 Several other drugs are in advanced 
stages of investigation, including isatuximab (a 
CD38 monoclonal antibody), marizomib and 
oprozomib (new proteasome inhibitors), ﬁ lanesib 
(a kinesin spindle protein inhibitor), dinaciclib (a 
cyclin dependent kinase inhibitor), venetoclax 
(a selective BCL-2 inhibitor), ACY-241 (a selective 
HDAC6 inhibitor), and LGH-447 (a pan-PIM kinase 
inhibitor).6 We are concerned that these therapeutic 
gains might not become a reality for patients because 
of the absence of a coherent strategy to tackle the 
heterogeneity of the disease, paucity of strategic trials, 
and high cost of treatment. We highlight key issues 
confronting the ﬁ eld, and propose possible solutions. 
These problems are likely to be a recurring theme in 
many other cancers, and therefore are relevant to the 
oncology community as a whole.
Multiple myeloma represents a heterogeneous 
collection of several diﬀ erent cytogenetically 
distinct plasma cell malignancies.7 These entities 
diﬀ er from each other in disease evolution, mode of 
presentation, response to therapy, and prognosis.8 
Studies to identify the best treatment regimens and 
sequence of therapy for each subset of the disease 
are urgently needed. Because researchers will not 
have adequate numbers of patients for prospective 
clinical trials in each category, we need comparative 
eﬀ ectiveness studies to compare outcomes with the 
latest regimens in patients with the most common 
cytogenetic subtypes. Additionally, studies speciﬁ cally 
targeting the optimal treatment of secondary 
cytogenetic abnormalities that are associated with 
adverse prognosis, such as del(17)(p), gain(1)(q21), 
and del(1)(p32), are also needed.9
Availability of active agents means that there will be 
many trials testing combinations of two versus three 
drugs or in the future three versus four drugs, resulting 
in numerous possible drug combinations. Many of 
these trials are essential for regulatory approval so 
that new drugs become available in a timely way to 
patients, but unfortunately they seldom inform the 
best strategy for treatment of the disease. To date, 
the optimal strategy for front-line therapy of multiple 
myeloma, the nature and duration of maintenance, 
or the ideal sequence of therapy at relapse cannot be 
deﬁ ned from available clinical trials. Some of these 
issues are to be expected, owing to the rapid pace of 
drug discovery, but more can be done to advance 
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